Gland Pharma Limited (GLAND) — Financial Results

· NSE Neutral
📢 Key Event
Trading window closure announced ahead of Q1 results
💡 Investor Takeaway
Retail investors must avoid trading GLAND shares until after the Q1 results are declared.

Gland Pharma announced that its trading window will close on June 27, 2026, ahead of the unaudited quarterly results for the quarter ending June 30, 2026, with the board meeting date to be announced later.

📄 View Original Announcement (PDF)

About Gland Pharma Limited (GLAND)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹30,781.44 Cr P/E: 43.7

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

📊 More GLAND filings

See all GLAND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAND — Free

Free account · 2 AI queries/day